Vimal Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 04-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 04-11-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.00 Cr
as on 04-11-2024
- Satisfied Charges ₹ 2.83 Cr
as on 04-11-2024
- Revenue 42.61%
(FY 2023)
- Profit -20.82%
(FY 2023)
- Ebitda -20.37%
(FY 2023)
- Net Worth 18.28%
(FY 2023)
- Total Assets -13.39%
(FY 2023)
About Vimal Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹16.00 Cr. The company has closed loans amounting to ₹2.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Susobhan Dutta, Paras Shah, and Bimal Shah serve as directors at the Company.
- CIN/LLPIN
U74120MH2014PTC255721
- Company No.
255721
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vimal Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Susobhan Dutta  | Director | 27-Jun-2014 | Current |
| Paras Shah | Director | 27-Jun-2014 | Current |
| Bimal Shah | Director | 27-Jun-2014 | Current |
Financial Performance of Vimal Life Sciences.
Vimal Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.61% increase. The company also saw a substantial fall in profitability, with a 20.82% decrease in profit. The company's net worth Soared by an impressive increase of 18.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vimal Life Sciences?
In 2023, Vimal Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vimal Intertrade Private LimitedActive 20 years 4 monthsParas Shah and Bimal Shah are mutual person
Vimal Specialty Films Private LimitedInactive For E-Filing 9 months 7 daysParas Shah and Bimal Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Dec 2020 | ₹8.00 Cr | Open |
Citi Bank N.A. Creation Date: 12 Dec 2017 | ₹8.00 Cr | Open |
Others Creation Date: 10 Jan 2017 | ₹2.83 Cr | Satisfied |
How Many Employees Work at Vimal Life Sciences?
Vimal Life Sciences has a workforce of 28 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vimal Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vimal Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
